CareCloud, Inc.
NASDAQ:CCLDMedical - Healthcare Information Services
+$0.04 today
- Market cap
- $101.27M
- Beta
- 1.51
- P/E (TTM)
- 9.7
- EPS (TTM)
- $0.23
Volume 0.53M
Average 0.58M
CCLD Other Financing Activities
Financing cash flows not reported separately.
CareCloud, Inc.NASDAQ: CCLD
Other Financing Activities · Q1 FY2026 · quarter ended Mar 2026
Other financing activities turns negative
Q1 FY2026 other financing activities was -$57K, compared with $0 a year earlier. Trailing-twelve-month other financing activities was -$5.67M. Over 3 fiscal years it compounded at -59.5% a year.
Context
- Other financing activities amounted to 0.1% of revenue in FY2025, up 0.1 pp from a year earlier.
- Other financing activities increased in 2 of the last 3 fiscal years.
What to watch
Whether quarterly other financing activities holds near -$57K or moves back toward the trailing-twelve-month quarterly average of -$1.42M.
Sources:Cash FlowText generated from reported figures; not investment advice.
Other Financing Activities history
USD · from the cash flow
- Latest · FY2025
- (148K) USD
- Year-over-year change
- —
| Period | Period end | Other Financing Activities | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | (148K) | — |
| FY2024 | 2024-12-31 | 0 | +100.0% |
| FY2023 | 2023-12-31 | (1.52M) | +31.6% |
| FY2022 | 2022-12-31 | (2.23M) | -5.0% |
| FY2021 | 2021-12-31 | (2.12M) | — |
Other Financing Activities vs competitors
How CCLD compares with its peers on the latest reported figures
- CCLD's LTM Mar 2026 other financing activities of $5.67M is the largest of the 10 companies compared; the peer median is $23K.
- Other financing activities amounts to 4.6% of revenue for CCLD, versus a peer median of 0.2%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Mar 2026 | $5.67M | — | -59.5% | 4.6% | |
| LTM Mar 2026 | $4.36M | — | — | — | |
| LTM Mar 2026 | $1.9M | -465.3% | +354.4% | 1.5% | |
TTRXTurn Therapeutics Inc. | LTM Mar 2026 | $1.07M | — | — | — |
| LTM Mar 2026 | $852K | -286.8% | — | 2.5% | |
IRDOpus Genetics, Inc. | LTM Mar 2026 | $112K | -99.2% | — | 0.9% |
| LTM Mar 2026 | $30K | +57.9% | — | 0.1% | |
| LTM Mar 2026 | $23K | +104.5% | — | 0.2% | |
| LTM Mar 2026 | $7K | -102.9% | — | 0.1% | |
| LTM Mar 2026 | $0 | — | — | 0.0% | |
| Peer median (excluding CCLD) | $23K | -101.1% | +354.4% | 0.2% | |
Competitors are the stored peer set for CCLD. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Net Income | 2.84M | 5.43M | (48.67M) | 7.85M | 10.8M |
| Depreciation & Amortization | 16.25M | 15.6M | 17.04M | 16.46M | 16.98M |
| Deferred Income Tax | 289K | 76K | (525K) | 0 | 0 |
| Stock-Based Compensation | 5.4M | 4.91M | 4.89M | 115K | 454K |
| Change in Working Capital | (10.79M) | (4.03M) | (1.11M) | (4.55M) | 454K |
| Accounts Receivables | (1.24M) | 1.82M | 1.55M | (460K) | 346K |
| Inventory | (104K) | 122K | (84K) | (109K) | 67K |
| Accounts Payables | (10.37M) | (6.59M) | (3.26M) | (4.65M) | 1.27M |
| Other Working Capital | 921K | 619K | 682K | 673K | (1.23M) |
| Other Non-Cash Items | (648K) | (842K) | 43.84M | 759K | (120K) |
| Operating Cash Flow | 13.33M | 21.15M | 15.46M | 20.64M | 28.56M |
| Capital Expenditures | (10.56M) | (11.77M) | (11.61M) | (1.7M) | (8.03M) |
| Acquisitions (Net) | (12.58M) | 0 | 0 | 0 | (16.51M) |
| Purchases of Investments | 0 | 0 | 0 | 0 | 0 |
| Sales of Investments | 0 | 0 | 0 | 0 | 0 |
| Other Investing Activities | (7.64M) | (9.18M) | (8.55M) | (5.71M) | (3.25M) |
| Investing Cash Flow | (23.15M) | (11.77M) | (11.61M) | (7.41M) | (24.54M) |
| Debt Repayment | 6.88M | (1M) | 1.11M | (10.68M) | 832K |
| Common Stock Issued | 9.17M | 0 | 0 | 0 | 0 |
| Common Stock Repurchased | 0 | 0 | 0 | (579K) | 0 |
| Dividends Paid | (14.44M) | (15.31M) | (14.3M) | 0 | (6.3M) |
| Other Financing Activities | (2.12M) | (2.23M) | (1.52M) | 0 | (148K) |
| Financing Cash Flow | (519K) | (7.65M) | (13.29M) | (11.26M) | (5.61M) |
| Effect of Forex Changes | (254K) | 225K | 469K | (166K) | 57K |
| Net Change in Cash | (10.59M) | 1.96M | (8.97M) | 1.81M | (1.53M) |
| Free Cash Flow | 2.77M | 9.38M | 3.85M | 18.95M | 20.53M |
CareCloud, Inc.
NASDAQ:CCLD
Intrinsic Alpha fair value
Locked
Current Price
$2.38
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.